Peripheral Spondyloarthritis Market

1. Executive Summary

2. Industry Introduction Taxonomy Market Definition

3. Market Trends and Success Factors Macro-economic Factors Market Dynamics Recent Industry Developments

4. Global Market Demand Analysis 2019 to 2023 and Forecast 2024 to 2034 Historical Analysis Future Projections

5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034

• 5.1. Treatment Type
• 5.2. Type of Disease
• 5.3. End User

6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Treatment Type

• 6.1. Disease-modifying Antirheumatic Drugs (DMARDs)
• 6.2. Non-steroidal Anti-inflammatory Drugs (NSAIDs)
• 6.3. Corticosteroids
• 6.4. Janus Kinase (JAK) Inhibitors

7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Type of Disease

• 7.1. Psoriatic Arthritis
• 7.2. Reactive Arthritis
• 7.3. Enteropathic Arthritis
• 7.4. Undifferentiated Peripheral Spondyloarthritis

8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End User

• 8.1. Hospitals & Clinics
• 8.2. Homecare Settings
• 8.3. Outpatient Centers

9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region

• 9.1. North America
• 9.2. Latin America
• 9.3. Western Europe
• 9.4. Eastern Europe
• 9.5. East Asia
• 9.6. South Asia & Pacific
• 9.7. Middle East & Africa (MEA)

10. North America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, By Key Segments and Countries

11. Latin America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, By Key Segments and Countries

12. Western Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, By Key Segments and Countries

13. Eastern Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, By Key Segments and Countries

14. East Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, By Key Segments and Countries

15. South Asia & Pacific Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, By Key Segments and Countries

16. MEA Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, By Key Segments and Countries

17. Sales Forecast 2024 to 2034 By Treatment Type, Type of Disease, and End User for 30 Countries

18. Competition Outlook, Market Structure Analysis, Company Share Analysis by Key Players, Competition Dashboard

19. Company Profile

• 19.1. AbbVie
• 19.2. Novartis
• 19.3. Pfizer
• 19.4. UCB Pharma
• 19.5. Janssen Biotech
• 19.6. Amgen
• 19.7. Bristol-Myers Squibb
• 19.8. Eli Lilly
• 19.9. Others